It’s become clear that there are many early indicators of health risks, and if treated/handled late, many health damages are irreversible. Moreover, treatments’ effectiveness (as we as other performance issues) depends on individuals’ history and genetics, as well as their pro-activeness and involvement in the planning process. This means we, as professionals, have to target and tailor diagnoses and treatment processes to the individual - not base our choices on generalities. This new school of personalized medicine demands more research and upfront investigation than most clinics and hospitals can do in-house. That’s where ConnectomeX can help.
We are always interested in hearing from healthcare professionals/managers, clinicians, biomedical informatics specialists, and data scientists about their ideas about and experiences of this process.